Navigation Links
Novel therapeutic agents provide hope for patients with hard-to-treat blood disorders
Date:12/9/2012

option superior to what is currently available for these patients," said Priya Koppikar, PhD, second author and research scholar in the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan-Kettering Cancer Center in New York.

"We believe these results provide the impetus for the first studies combining ruxolitinib with HSP90 inhibitors in myelofibrosis patients, and we are working to begin these trials as soon as possible to improve their outcomes," added Ross Levine, MD, lead author and Associate Attending Physician in the HOPP and Leukemia Service at Memorial Sloan-Kettering Cancer Center in New York.

Dr. Koppikar will present this study in an oral presentation on Monday, December 10, at 6:15 p.m. EST at the Georgia World Congress Center in Room B216-B217, Level 2, Building B.

A Pivotal Phase II Trial of Ponatinib in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Resistant or Intolerant to Dasatinib or Nilotinib, or with the T315I BCR-ABL Mutation: 12-Month Follow-up of the PACE Trial [Abstract 163]

Researchers have discovered that ponatinib, a new oral tyrosine-kinase inhibitor (TKI), can silence a deadly mutation in chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphocytic leukemia (Ph+ALL).

CML and Ph+ALL are leukemias caused by an abnormality known as the Philadelphia chromosome that produces the cancer-causing gene BCR-ABL. This gene provides the DNA code to produce the BCR-ABL tyrosine-kinase, a protein found on the leukemia cell surface critical to its development. TKIs such as imatinib, dasatinib, and nilotinib, which bind to the protein and "turn off" its signal, have been revolutionary in the treatment of leukemia and have quickly become standard first-line therapies for CML and Ph+ALL.

'/>"/>
Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Researchers develop novel 3-D culture system for inflammatory breast cancer
2. ACNP: Novel NMDA receptor modulator significantly reduces depression scores within hours
3. Scripps Florida scientists uncover a novel cooperative effort to stop cancer spread
4. Novel mechanism through which normal stromal cells become cancer-promoting cells identified
5. Novel breast screening technology increases diagnostic accuracy
6. UNC, Vanderbilt discover a new live vaccine approach for SARS and novel coronaviruses
7. Moffitt Cancer Center researchers identify novel metabolic programs driving aggressive brain tumors
8. Novel treatment strategies for epilepsy
9. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
10. Researchers ID potential patient population who may benefit from novel anti-platelet treatment
11. Undertreatment of common heart condition persists despite rapid adoption of novel therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 05, 2015 , ... The ... a 2015-2016 inductee into its VIP Woman of the Year Circle. She is ... leading networking organization exclusively for professional women, boasting more than 700,000 members and ...
(Date:8/4/2015)... , ... August 04, 2015 , ... Statement by Paul ... the introduction of the Mental Health Reform Act of 2015 by Senators ... mental health reform a reality in America. , “This legislation and H.R. ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... announces the Assisted Dumbbell Bench Rack, a fitness invention that eliminates the need ... "The Gym, Health and Fitness Clubs industry is worth $30 billion," says Scott ...
(Date:8/4/2015)... , ... August 04, 2015 , ... Atlantic Health System, ... Place to Work® and Fortune among the top five in their list of the ... of Morristown, Overlook, Newton and Chilton Medical Centers, Goryeb Children’s Hospital and Atlantic Rehabilitation, ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... organization which provides vascular, electrocardiogram (EKG), echocardiogram, and NCV testing, announced their ... been successfully identifying previously undiagnosed cardiovascular abnormalities one program at a time. ...
Breaking Medicine News(10 mins):Health News:NAPW Inducts Deborah Stevens, Executive Assistant to Chairman and CEO at Mirion Technologies, Inc., Into its VIP Woman of the Year Circle 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 2Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 3Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 4Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 5Health News:As The Navy Changes Body-Fat Rules, the World Patent Marketing Review Team Announces the Development of the Assisted Dumbbell Bench Rack 6Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 2Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 3Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 4Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 3
... effects, including reduced strength after shots, study finds , ... smoothes facial wrinkles through injections of the drug Botox, ... a new study finds. , But the researchers warn ... potentially nettlesome side effect, according to the report published ...
... first time succeeded in extracting vital stem cells from ... funded by the British Heart Foundation (BHF) found that ... grow, which could potentially help repair damaged heart muscle ... Madeddu, Professor of Experimental Cardiovascluar Medicine and his team ...
... ... printing products, today announced it is ready for immediate shipping of thousands of items ... customer service or instantly online from the company’s award winning web site My1Stop.com. ... Ft. Scott, Kansas ...
... KAMPALA Rationing Funds, Risking Lives: World Backtracks on ... Preparedness Coalition (ITPC), documents early warning signs resulting from ... on the number of people enrolled in treatment programs, ... falling short. "AIDS is not over. ITPC,s ...
... ... dentist, publishes new e-book that helps people choose the right dentist to perform dental implant ... (PRWEB) April ... has launched her newest e-book, Dental Implants: The Five Questions You Must Ask ...
... ... for healthy pregnancies, Reproductive Medicine Associates of Connecticut (RMACT) sponsored this year,s March for ... , ... April 25, 2010 -- Finding synergy in their missions for healthy pregnancies, Reproductive Medicine ...
Cached Medicine News:Health News:Botox Injections May Relieve Tennis Elbow Pain 2Health News:Stem cells from surgery leftovers could repair damaged hearts 2Health News:My1Stop.com New Packaging Supplies Offering for Distribution Centers and Small Business Shipping 2Health News:New report confirms fears of people living with HIV: Treatment rationing escalating 2Health News:New report confirms fears of people living with HIV: Treatment rationing escalating 3Health News:New report confirms fears of people living with HIV: Treatment rationing escalating 4Health News:New E-Book Explains the Facts About Dental Implants 2Health News:Fertility Clinic Shows Support for Healthy Pregnancies By Sponsoring March of Dimes "March for Babies" 2Health News:Fertility Clinic Shows Support for Healthy Pregnancies By Sponsoring March of Dimes "March for Babies" 3
(Date:8/4/2015)... , Aug. 4, 2015 Research and Markets ... "Alcohol Ethoxylate Market by Application (Household & Personal ... Market Trends, Forecasts to 2019" report to their ... ethoxylate was valued at $5,124.9 million in 2014 and ... 3.5% from 2014 to 2019. The data mentioned in ...
(Date:8/4/2015)... 4, 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: ... development and commercialization of targeted antiviral therapies, today ... will present live at VirtualInvestorConferences.com on August 6, ... TIME: 12:15PM EDT LINK: http://tinyurl.com/aug6-pre-ctrv ... online event where investors are invited to ask ...
(Date:8/4/2015)... Aug. 4, 2015 ANI Pharmaceuticals, Inc. ("ANI") ... the three and six months ended June 30, 2015 ... will host its earnings conference call this morning, August ... interested parties can join the call by dialing (855) ... Highlights Include: , Year-to-date net revenues of $38.3 million, ...
Breaking Medicine Technology:Global Alcohol Ethoxylate Market 2015 - Market Trends, Forecasts to 2019 for the $5.1 Billion Industry 2Global Alcohol Ethoxylate Market 2015 - Market Trends, Forecasts to 2019 for the $5.1 Billion Industry 3ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 2ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 3ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 2ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 3ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 4ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 5ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 6ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 7ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 8ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 9ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 10ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 11ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 12ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 13ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 14ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 15ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 16
... CEL-SCI Corporation,(Amex: CVM ) announced today that it ... its lead drug Multikine(R) on October 8, 2008.,This dedicated ... for,CEL-SCI,s pivotal Phase III clinical trial for first-line therapy ... for,sale following approval of the drug. The facility, which ...
... 0901 is Being Developed as an Oral Dosage Form ... at Improving Glycemic Control in Adults With Type 2 ... (OTCBB: ORMP.OB), a developer of oral drug delivery,systems, announced ... a GLP1-analog., ORMD 0901 belongs to the Incretin ...
Cached Medicine Technology:CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008 2CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008 3Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform 2
... Flexible monitoring for intermediate care., ,The ... GE Healthcare Datex-Ohmeda S/5 product line., ,The ... you the power to grow. The new Patient ... hemodynamic measurements up to 12-lead ECG, NIBP, ...
... wireless connectivity, ,The wireless functionality is ... system that makes it possible to connect ... the S/5 Central Station via Wireless LAN ... way of providing continuous centralized surveillance within ...
... and recovery room, ,The Cardiocap II ... and airway gas monitoring for induction rooms, ... The Cardiocap II is available in 4 ... measurements. Two of the models include built-in ...
Precordial Chestpieces are manufactured from chrome plated brass. Provides a hollow design with deep sound chambers for optimum acoustics....
Medicine Products: